Overview

Effect of MK0524A on Cholesterol Levels (0524A-048)

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
0
Participant gender:
All
Summary
The primary objective of the study is to assess the effects of MK0524A in reducing cholesterol levels in an Asian population.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Niacin
Niacinamide
Nicotinic Acids
Criteria
Inclusion Criteria:

- Patient is male or female between 18 and 70 years of age

- Females of reproductive potential must agree to take acceptable contraceptive
precautions for the duration of the study

Exclusion Criteria:

- Patient has a history of not being able to take niacin or niacin-containing products

- Patient consumes more than 2 alcoholic beverages per day

- Patient has poorly controlled Type 1 or Type 2 diabetes mellitus

- Patient engages in vigorous exercise or an aggressive diet regimen